Previous studies have demonstrated high levels of tumor-infiltrating lymphocytes (TIL) with promising prognosis in NSCLC, which infiltrated more CD8 positive, CD3 positive, and CD4 positive TIL (27). The gene discussed is CD4; the disease is neoplasm.